Isotechnika Pharma Inc IPHAF

RE: timeline

[biodelatech]

so what clinical trials take their time and the carcinogenicity study can´t be done in a fortnight either. all this whining about why it takes so long is a sign of uncleverness. the clever investors see the clinical data and looks at the market cap and makes his/her moves = buy it cheaply and wait. I admit that if the start of selling of 247 wasn´t so far out the stock would be sharply higher and keep its gains. but assuming positive 24 week data and a flawless and positive second phase 3 and a good outcome of the carcinogenicity study and worldwide approval the stock will be somewhere between 50 and 100 C$. But in the meantime I ´m going to ponder what to buy with my return on my isa investment.